Cardiovascular, Neuropeptides, and Oxidative Stress Research
Cardiovascular, Neuropeptides, and Oxidative Stress Research is a research topic within Surgery. Science Explorer counts 9.2k research works in it since 1951. 21.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of Urotensin II in cardiovascular physiology and disease, focusing on its vasoconstrictor activity, impact on hypertension, atherosclerosis, endothelial dysfunction, and renal function. It also discusses the development of receptor antagonists and its involvement in smooth muscle cell proliferation and the neuroendocrine system.
- Urotensin II
- Cardiovascular Disease
- Vasoconstriction
- Hypertension
- Atherosclerosis
- Receptor Antagonist
- Smooth Muscle Cell Proliferation
- Endothelial Dysfunction
- Renal Function
- Neuroendocrine System
- Research works
- 9.2k fractional, since 1951
- In the world top 10%
- 2k per year above
- Top-10% rate
- 21.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +11% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cardiovascular, Neuropeptides, and Oxidative Stress Research research?
By volume, China and the United States publish the most (306 and 163 works in 2022–2025).
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cardiovascular, Neuropeptides, and Oxidative Stress Research research?
By volume in 2022–2025, Nanjing Medical University publishes the most Cardiovascular, Neuropeptides, and Oxidative Stress Research research, followed by Medical University of Warsaw and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 Nanjing Medical UniversityChina 5 works
- 2 Medical University of WarsawPoland 4 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 4 works
- 4 Medical University of BiałystokPoland 4 works
- 5 University of MissouriUnited States 4 works
- 6 Sun Yat-sen UniversityChina 4 works
- 7 Universidade de São PauloBrazil 3 works
- 8 InsermFrance 3 works
- 9 Ain Shams UniversityEgypt 3 works
- 10 Capital Medical UniversityChina 3 works
Who are the leading researchers in Cardiovascular, Neuropeptides, and Oxidative Stress Research?
The most-cited researchers publishing on Cardiovascular, Neuropeptides, and Oxidative Stress Research include Rhian M. Touyz.
- 1 Rhian M. Touyz United Kingdom 3.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cardiovascular, Neuropeptides, and Oxidative Stress Research research done?
The largest centres of Cardiovascular, Neuropeptides, and Oxidative Stress Research research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Paris (France).
Is Cardiovascular, Neuropeptides, and Oxidative Stress Research research growing?
Output in 2018–2022 was 11% higher than in 2013–2017, peaking in 2020. The fastest-growing topics are Cardiovascular, Neuropeptides, and Oxidative Stress Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.